Xeriant, Inc.
XERI· OTC
XERIXeriant, Inc.
Filed May 23, 2017 · 10-Q · 53 days after period end · 0001477932-17-002496
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $133.41K | $446.51K | $582.10K | $716.14K |
| Net Income | -$255.97K | -$160.09K | -$151.31K | -$142.04K |
| EPS Diluted | $0.00 | $0.00 | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xeriant, Inc. · CIK 1481504 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 23, 2017 · 53 d after period end
